Skip to main content

Table 6 Cats experiencing the most common adverse reactions reported during the study

From: A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA

Adverse reaction

Lotilaner treatment group (n = 228)

Fipronil + S-methoprene treatment group (n = 113)

Weight loss

5 (2.2%)

2 (1.8%)

Tachypnea

3 (1.3%)

0 (0.0%)

Vomiting

3 (1.3%)

1 (0.9%)

  1. Values in table are presented as the number of cas with the adverse reaction, with the percentage in parentheses